Novel hormonal therapy for castration-resistant prostate cancer

被引：8
|
作者：
Sternberg, C. N. [1 ]
机构：
[1] San Camillo Forlanini Hosp, Dept Med Oncol, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
abiraterone; enzalutamide; hormone therapy; prostate cancer; ACETATE PLUS PREDNISONE; ABIRATERONE ACETATE; ANDROGEN RECEPTOR; ANTITUMOR-ACTIVITY; KETOCONAZOLE; ANTIANDROGEN; DOCETAXEL; CYP17; INHIBITION; SURVIVAL;
D O I：
10.1093/annonc/mds362
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：259 / 263
页数：5
相关论文
共 50 条
  • [41] Combining next-generation hormonal therapy with PARP inhibition in metastatic castration-resistant prostate cancer
    Abida, Wassim
    Attard, Gerhardt
    [J]. LANCET, 2023, 402 (10398): : 266 - 267
  • [42] Darolutamide For Castration-Resistant Prostate Cancer
    Bastos, Diogo A.
    Antonarakis, Emmanuel S.
    [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 8769 - 8777
  • [43] Advances in the treatment of castration-resistant prostate cancer: emphasis in new hormonal therapies
    Berlin, Alejandro
    Fernandez, Mario I.
    [J]. REVISTA MEDICA DE CHILE, 2015, 143 (02) : 223 - 236
  • [44] Intratumoral steroidogenesis in castration-resistant prostate cancer: a target for therapy
    Armandari, Inna
    Hamid, Agus Rizal
    Verhaegh, Gerald
    Schalken, Jack
    [J]. PROSTATE INTERNATIONAL, 2014, 2 (03) : 105 - 113
  • [45] Castration-Resistant Prostate Cancer-Hormone Therapy Redux
    Tolcher, Anthony W.
    Cooper, Josh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (09) : 1447 - 1449
  • [46] Second line therapy for castration-resistant prostate cancer (CRPC)
    Molitor, B.
    Boergermann, C.
    [J]. UROLOGE, 2012, 51 (03): : 357 - 362
  • [47] Current possibilities of drug therapy for castration-resistant prostate cancer
    Markova, A. S.
    [J]. ONKOUROLOGIYA, 2013, 9 (02): : 73 - 77
  • [48] Wnt signaling in castration-resistant prostate cancer: implications for therapy
    Yokoyama, Noriko N.
    Shao, Shujuan
    Hoang, Bang H.
    Mercola, Dan
    Zi, Xiaolin
    [J]. AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2014, 2 (01): : 27 - 44
  • [49] Supraphysiological Testosterone Therapy as Treatment for Castration-Resistant Prostate Cancer
    Lam, Hung-Ming
    Corey, Eva
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [50] Genomic Strategy for Targeting Therapy in Castration-Resistant Prostate Cancer
    Mendiratta, Prateek
    Mostaghel, Elahe
    Guinney, Justin
    Tewari, Alok K.
    Porrello, Alessandro
    Barry, William T.
    Nelson, Peter S.
    Febbo, Phillip G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) : 2022 - 2029
12345